The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2019 | CLL trial highlights from 15-ICML
Ahmad Alhuraiji
• 20 Jun 2019
Ahmad Alhuraiji, MD, of the Kuwait Cancer Control Center, Kuwait City, Kuwait, discusses three major chronic lymphocytic leukemia (CLL) trials that were presented at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland. These include a Swiss trial, CLL14 (NCT02242942), and CLL12 (NCT02863718).
